Biomarker progress offers hope for early autism spectrum disorder detection

Autism spectrum disorders (ASD) are neurodevelopmental disorders typically characterized by difficulties in social interactions and delayed or abnormal language development. Although ASD reportedly affects 1 in 88 people in the United States, to date there have been no distinctive biomarkers to diagnose the disease. In a special themed issue of Disease Markers, investigators report on the current understanding of ASD genetics and the possibilities of translating genetic research toward biomarker development in ASD.

Read more at: http://medicalxpress.com/news/2012-11-biomarker-early-autism-spectrum-disorder.html#jCp

No comments:

Post a Comment